Fig. 2From: Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosisKaplan–Meier curves for rivaroxaban and dabigatran groups. Complete recanalization (A), partial recanalization (B) and persistent occlusion (C) of PVTBack to article page